跳转至内容
Merck
CN

238643

Sigma-Aldrich

IGEPAL® CO-520

average Mn 441

别名:

聚氧代乙烯(5)壬基苯基醚,支化

登录查看公司和协议定价


About This Item

线性分子式:
(C2H4O)n · C15H24O, n~5
CAS号:
MDL编号:
UNSPSC代码:
12162002
PubChem化学物质编号:
NACRES:
NA.23

分子量

average Mn 441

质量水平

折射率

n20/D 1.496 (lit.)

密度

0.997 g/mL at 25 °C (lit.)

HLB

10

SMILES字符串

CCCCCCCCCc1ccc(O)cc1.OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

InChI

1S/C24H50O13.C15H24O/c25-1-3-27-5-7-29-9-11-31-13-15-33-17-19-35-21-23-37-24-22-36-20-18-34-16-14-32-12-10-30-8-6-28-4-2-26;1-2-3-4-5-6-7-8-9-14-10-12-15(16)13-11-14/h25-26H,1-24H2;10-13,16H,2-9H2,1H3

InChI key

SUJLMNLVFQRPGM-UHFFFAOYSA-N

一般描述

IGEPAL®CO-520或聚(氧乙烯)壬基苯基醚是一种非离子表面活性剂。

应用

Igepal聚集体已可用于荧光和光散射研究。用于制备单分散二氧化硅硫化镉纳米复合材料, 氧化铝纳米颗粒, 超薄二氧化硅包覆磁性纳米颗粒。

法律信息

IGEPAL is a registered trademark of Solvay

象形图

Environment

警示用语:

Warning

危险声明

预防措施声明

危险分类

Aquatic Acute 1 - Aquatic Chronic 1

储存分类代码

10 - Combustible liquids

WGK

WGK 3

闪点(°F)

380.3 °F - closed cup

闪点(°C)

193.5 °C - closed cup

法规信息

监管及禁止进口产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Preparation and properties of tailored morphology, monodisperse colloidal silica-cadmium sulfide nanocomposites.
Chang SY, et al.
Journal of the American Chemical Society, 116(15), 6739-6744 (1994)
Ming Zhang et al.
Nanotechnology, 19(8), 085601-085601 (2008-02-27)
A systematic study of the formation of silica-coated magnetite particles via a modified reverse microemulsion approach was investigated by using transmission electron microscopy (TEM), x-ray diffraction (XRD) and a superconducting quantum interference device (SQUID). The results show that the surfactant
Aggregation of non ionic surfactant Igepal in aqueous solution: fluorescence and light scattering studies
Ghosh SK, et al.
International Journal of Molecular Sciences, 4, 562-571 (2003)
Synthesis and characterization of alumina nanoparticles by igepal CO-520 stabilized reverse micelle and sol-gel processing
Chandradass J and Bae DS
Materials and Manufacturing Processes, 23(5), 494-498 (2008)
Mirko Trilling et al.
Journal of virology, 83(8), 3684-3695 (2009-02-13)
Vaccinia virus (VACV) replicates in mouse and human fibroblasts with comparable kinetics and efficiency, yielding similar titers of infectious progeny. Here we demonstrate that gamma interferon (IFN-gamma) but not IFN-alpha or IFN-beta pretreatment of mouse fibroblasts prior to VACV infection

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门